QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD
QIPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 104 industry peers in the Health Care Providers & Services industry. QIPT may be in some trouble as it scores bad on both profitability and health. QIPT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIPT has reported negative net income.
QIPT had a positive operating cash flow in the past year.
QIPT had negative earnings in 4 of the past 5 years.
QIPT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.99%, QIPT is doing worse than 60.58% of the companies in the same industry.
QIPT has a Return On Equity (-6.83%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.14%, QIPT perfoms like the industry average, outperforming 40.38% of the companies in the same industry.
QIPT had an Average Return On Invested Capital over the past 3 years of 2.55%. This is significantly below the industry average of 9.36%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROIC | 0.14% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
1.3 Margins
QIPT has a Operating Margin of 0.14%. This is comparable to the rest of the industry: QIPT outperforms 40.38% of its industry peers.
The Gross Margin of QIPT (71.56%) is better than 88.46% of its industry peers.
QIPT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
QIPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QIPT has more shares outstanding than it did 1 year ago.
QIPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, QIPT has a worse debt to assets ratio.
2.2 Solvency
QIPT has an Altman-Z score of 0.46. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of QIPT (0.46) is worse than 74.04% of its industry peers.
The Debt to FCF ratio of QIPT is 4.91, which is a neutral value as it means it would take QIPT, 4.91 years of fcf income to pay off all of its debts.
QIPT has a Debt to FCF ratio of 4.91. This is in the better half of the industry: QIPT outperforms 69.23% of its industry peers.
QIPT has a Debt/Equity ratio of 0.74. This is a neutral value indicating QIPT is somewhat dependend on debt financing.
QIPT has a Debt to Equity ratio (0.74) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Altman-Z | 0.46 |
ROIC/WACC0.02
WACC7.54%
2.3 Liquidity
QIPT has a Current Ratio of 1.22. This is a normal value and indicates that QIPT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, QIPT is in line with its industry, outperforming 40.38% of the companies in the same industry.
QIPT has a Quick Ratio of 1.22. This is a bad value and indicates that QIPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QIPT has a worse Quick ratio (0.87) than 70.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -90.91%.
QIPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.92%.
Measured over the past years, QIPT shows a very strong growth in Revenue. The Revenue has been growing by 32.16% on average per year.
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
3.2 Future
The Earnings Per Share is expected to grow by 97.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, QIPT will show a very strong growth in Revenue. The Revenue will grow by 21.85% on average per year.
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue Next Year-9.29%
Revenue Next 2Y-4.42%
Revenue Next 3Y-2.39%
Revenue Next 5Y21.85%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QIPT is valued cheaper than 95.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaply inside the industry as 96.15% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.32 | ||
| EV/EBITDA | 3.99 |
4.3 Compensation for Growth
A more expensive valuation may be justified as QIPT's earnings are expected to grow with 16.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.9%
EPS Next 3Y16.35%
5. Dividend
5.1 Amount
QIPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:QIPT (8/15/2025, 8:00:01 PM)
2.04
+0.05 (+2.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners45.65%
Inst Owner Change-20.12%
Ins Owners15.15%
Ins Owner Change53.95%
Market Cap88.62M
Analysts82
Price Target4.17 (104.41%)
Short Float %2.84%
Short Ratio0.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.98%
Min EPS beat(2)-124.09%
Max EPS beat(2)32.12%
EPS beat(4)1
Avg EPS beat(4)-255.78%
Min EPS beat(4)-540.96%
Max EPS beat(4)32.12%
EPS beat(8)1
Avg EPS beat(8)-522.14%
EPS beat(12)3
Avg EPS beat(12)-242.54%
EPS beat(16)4
Avg EPS beat(16)-226.56%
Revenue beat(2)0
Avg Revenue beat(2)-11.63%
Min Revenue beat(2)-20.53%
Max Revenue beat(2)-2.74%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-2.74%
Revenue beat(8)1
Avg Revenue beat(8)-4.62%
Revenue beat(12)1
Avg Revenue beat(12)-4.57%
Revenue beat(16)2
Avg Revenue beat(16)-4.02%
PT rev (1m)-20.95%
PT rev (3m)-35.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-5.91%
Revenue NY rev (3m)-5.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.37 | ||
| P/FCF | 4.32 | ||
| P/OCF | 2.69 | ||
| P/B | 0.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.99 |
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.47
FCFY23.16%
OCF(TTM)0.76
OCFY37.18%
SpS5.57
BVpS2.45
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROCE | 0.18% | ||
| ROIC | 0.14% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.5% | ||
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% | ||
| FCFM | 8.48% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
ROICexc(3y)2.81%
ROICexc(5y)N/A
ROICexgc(3y)9.78%
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Debt/EBITDA | 1.82 | ||
| Cap/Depr | 28.74% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.46 |
F-Score3
WACC7.54%
ROIC/WACC0.02
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
Revenue Next Year-9.29%
Revenue Next 2Y-4.42%
Revenue Next 3Y-2.39%
Revenue Next 5Y21.85%
EBIT growth 1Y-93.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1615.9%
EBIT Next 3Y157.9%
EBIT Next 5Y154.85%
FCF growth 1Y23.94%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y26.48%
OCF growth 3Y23.7%
OCF growth 5Y33.42%